Articles closely related to the subject of the thesis and cited in the thesis 1) L. Judák, P. Hegyi, Z. Rakonczay Jr., J. Maléth,M.A. Gray, V. Venglovecz. EtOH and its nonoxidative metabolites profoundly inhibit CFTR function in pancreatic epithelial cells which is prevented by ATP supplementation.
INTRODUCTION
The exocrine pancreas consist of two main cell types: the acinar and the ductal cells.
The digestive enzymes are synthetized and secreted by the acinar cells, whereas the ductal cells secrete a bicarbonate-rich isotonic solution which is essential for the transport of digestive enzymes into the duodenum, and insures an optimal pH environment. The human pancreatic ductal system secretes about 2 litres of pancreatic juice per day, which containing as much as 140 mmol/l HCO 3 -at maximal stimulation. Previous studies indicated that reduced or deficient fluid and HCO 3 -secretion leads to the destruction of the pancreas, and causes different pancreatic diseases, such as cystic fibrosis. AP is a sudden and severe disease characterized by local complications and/or systemic organ failure. Heavy alcohol consumption is one of the leading causes of AP, however, the cellular mechanism by which ethanol (EtOH) induces pancreatitis is not well understood. The effects of EtOH or its metabolites on the pancreas were mainly investigated on acinar and stellate cells whereas much less studies have been done on PDECs. Yamamoto et al. showed that low concentrations (0.3-30mM) of EtOH augmented ductal fluid secretion stimulated with physiological or pharmacological concentrations of secretin, whereas a high concentration of EtOH (100 mM) completely abolished this effect. However, no data is available regarding the effect of EtOH or its metabolites on the activity of CFTR Cl -channel.
It is generally accepted that inappropriate or premature activation of digestive enzymes leads to autodigestive injury and therefore is a key event in the development of chronic or acute pancreatitis. Under physiological conditions, trypsinogen is synthesized by the acinar cells as inactive precursor, transferred to the duodenum via the pancreatic ducts, and then activated by enteropeptidases in the small intestine. Several studies indicated that trypsin stimulates enzyme secretion from acinar cells via proteinase-activated receptor-2 (PAR-2). In contrast the effect of trypsin on ductal HCO 3 -secretion is contradictory, highly depends on the species and the localization of PAR-2. In these studies the effect of trypsin was investigated on the activity of the Cl -/HCO 3 -exchanger, whereas no data is available regarding the effect of trypsin on CFTR.
AIMS
The main aims of this work were to investigate the role of CFTR Cl -channel in PDEC physiology.
1. To investigate the direct effects of EtOH and its metabolites on CFTR Cl -channel.
2.To examine the effects of trypsin on CFTR Cl -channel.
MATERIALS AND METHODS

Capan-1 cell culture
Capan-1 cells were grown in Roswell Park Memorial Institute (RPMI)-1640 Medium supplemented with 15 % fetal bovine serum, 1 % penicillin-streptomycin. Cells from passage numbers 20-60 were used in this study. For electrophysiological measurements, 5×10 5 cells were plated onto 24 mm diameter glass coverslips and used for experiments after 3 to 4 days of culture (~60-80 % confluency).
Isolation of pancreatic ductal cells
Four-to eight-week-old guinea pigs were humanly killed by cervical dislocation and then the pancreas was removed. Intra/interlobular ducts were isolated by enzymatic digestion and microdissection from the pancreas and then cultured overnight as previously described.
To obtain single pancreatic ductal cells, cultured ducts were incubated for 50 min at 37°C in 50 U/ml elastase dissolved in storage solution (Dulbecco's modified Eagle's medium containing 3 % (w/v) bovine serum albumin (pH 7.4 with NaOH)). The ducts were then washed in a Ca 2+ / Mg 2+ -free Kreb's-Ringer HEPES buffer (pH 7.4) for 10 min further in order to stop elastase activity. After the incubation, ducts were teased apart using stainless steel needles.
In the patch clamp experiments, one drop of cell suspension was placed within a transparent recording chamber, and single ductal cells were allowed to settle and attach to the bottom of the chamber for at least 30 min before perfusion was initiated. In the microfluorometric measurements, one drop of cell suspension was transferred to a poly-llysine-coated cover slip (24 mm) forming the base of a perfusion chamber. Cells were then washed continuously with solutions at a rate of 1.5 or 5-6ml/min in the patch-clamp and microfluorometric measurements, respectively. Individual ductal cells were used within 3-4 h after the isolation. mOsm/l. In some experiments, the ATP concentration was increased to 2 or 5 mM.
Whole cell current recording
After establishing a high (1-10 GOhm) resistance seal by gentle suction, the cell membrane was disrupted by further suction or by applying a 1.5 V electrical pulse for 1-5ms.
The series resistance was tipically 4-8 MOhm before compensation (50-80 %, depending on the voltage protocol). Membrane currents were digitized using a 333-kHz analog-to-digital converter (Digidata 1200, Molecular Devices-Axon Instruments, Union City, CA, USA) after low-pass filtering at 1 kHz under software control (PCLAMP 6.0, Molecular Devices-Axon
Instruments, Union City, CA, USA). To obtain current/voltage (I/V) relationships, the membrane potential (V m ) was held at 0 mV and then clamped to ±100 mV in 20 mV increments for 500 ms, with an 800 ms interval between each pulse. Currents were measured over a 4 ms period starting 495 ms into the voltage pulse. Mean current amplitudes were calculated at ± 60 mVand normalised to cell capacitance (pF). 
Measurement of intracellular ATP
RESULTS
Measurement of CFTR conductance in guinea pig PDECs
Our experimental conditions were designed to selectively study CFTR channel activity in PDECs as described previously. In order to block potassium conductances, we used a CsClrich pipette solution, whereas Ca 2+ -activated Cl -currents were inhibited by using 5 mM intracellular EGTA to lower Ca 2+ levels to ~10 nM. After establishing a whole cell recording, a small resting current was observed (23±2.5 pA/pF at ± 60 mV), with a mean reversal potential of −5.6 mV, which is very close to the Cl -equilibrium potential (~ −5.7 mV).
Administration of 5 µM forskolin (cAMP agonist) to the bathing solution increased whole cell currents by approximately tenfold in 70 % of cells. To confirm that the basal and stimulated currents were both mediated by CFTR, we tested CFTR inh -172, a potent inhibitor of the channel. Administration of 10 µM CFTR inh -172 reversibly and significantly blocked the basal currents by 58.2 ± 5.7 % (at + 60 mV) and forskolin-stimulated currents by 66.6 ± 6.4 % (at + 60 mV), providing further evidence that under our experimental conditions the whole cell currents were due to CFTR.
EtOH increases the basal but inhibits the forskolin-stimulated CFTR currents
We examined the effect of 1-100 mM EtOH on both basal and forskolin-stimulated whole cell currents. Exposing duct cells to 1 mM EtOH had no significant effect on basal or forskolin-activated CFTR currents, even after 15 min of administration. Increasing the EtOH concentration to 10 mM significantly increased the basal current by 32.6 ± 10.2 % after 15 min of administration at + 60 mV, whereas 100 mM EtOH induced a robust increase within 5 min. In contrast, both 10 and 100 mM EtOH blocked the forskolin-stimulated whole cell currents. Both the stimulatory and inhibitory effects of EtOH were reversible on washout. In addition, block by EtOH was not voltage dependent.
The rate of the mannitol-induced increase in whole cell currents was similar to the rate of EtOHinduced increase, indicating that the stimulatory effect of a high concentration of
EtOH on the basal current is likely to be via an osmotic effect. In contrast to EtOH, mannitol did not decrease but significantly increased the forskolinstimulated currents by 49.7 ± 10.2 % (after 15 mins at + 60 mV), suggesting that the inhibitory effect of EtOH is independent of its osmotic effect.
Effects of EtOH metabolites on basal and forskolin-stimulated CFTR currents
POAEE, an unsaturated non-oxidative metabolite of EtOH, also had no effect on the forskolin-stimulated whole cell currents, indicating that BNPP alone has no effect on CFTR activity. In contrast, BNPP treatment almost completely abolished the inhibitory effect of POAEE on forskolin-stimulated currents, strongly suggesting that formation of POA is a crucial step in the inhibitory effect of POAEE/EtOH.
EtOH, POAEE and POA cause ATPi depletion in PDECs, which is linked to CFTR inhibition
We next investigated the intracellular mechanism by which EtOH, and its non- induced a marked increase in MgGreen fluorescence intensity, whichreached a plateau about 5 min after the administration of the metabolites. We have previously shown that inhibitors of both oxidative and glycolytic metabolism, carbonyl cyanide m-chlorophenyl hydrazone (CCCP; 100 µM) and 2-deoxyglucose/iodoacetamide (DOG/IAA; 10 mM), respectively, caused a marked and irreversible depletion of ATP i in guinea pig pancreatic ductal cells.
In order to decide whether the inhibitory effect of EtOH, POA and POAEE on CFTR was linked to the depletion of ATP i , we tested the effect of CCCP/DOG/IAA administration on CFTR currents and found that this combination of inhibitors blocked both the basal and forskolin-stimulated currents in a similar manner to EtOH, POA and POAEE. After the removal of CCCP/DOG/IAA from the external solution, the currents did not return to the initial levels, indicating that CCCP/DOG/IAA irreversibly inhibit CFTR, probably due to the maintained depletion of ATP i .
Intracellular ATP supplementation reverses the inhibitory effect of EtOH, POAEE and POA on CFTR activity in PDECs
To investigate further the apparent relationship between the inhibitory effect of EtOH, POA and POAEE on CFTR channel activity and depletion of ATP i , we tested whether raising ATP i levels in PDECs would result in a better tolerance to these agents. Increasing the ATP i concentration in the pipette solution from 1 mM to either 2 or 5 mM did not produce a detectable alteration in the size, or properties, of the basal or forskolin-stimulated CFTR currents, suggesting that ATP was not limiting for CFTR activity under all conditions. Next, we studied the effect of 100 mM EtOH, 200 µM POAEE or 200 µM POA on CFTR currents in the presence of 2 mM ATP in the pipette. Supplementation of the pipette solution with 2 mM ATP did not influence the effects of EtOH or its non-oxidative metabolites on CFTR currents (data not shown). In contrast, increasing the ATP concentration to 5 mM completely prevented the inhibitory effect of EtOH and POAEE on forskolin-stimulated currents, as well as the effect of POA on the basal and forskolin-stimulated CFTR currents. These results indicate that inhibition of CFTR by EtOH//POAEE/POA is likely due to a reduction of ATP i and/or to a change in ATP i interaction with CFTR.
Low concentration of EtOH stimulates whereas high concentrations of EtOH and fatty acids inhibit forskolin-stimulated CFTR currents in human PDECs
To extend these studies to human PDECs, we used a human ductal adenocarcinoma cell line, Capan-1, which has been shown to express CFTR. We used the same concentrations of EtOH, POA and POAEE than on guinea pig PDEC and we found similar results.
Consequently, patch-clamp experiments revealed that 10 mM EtOH increased, whereas, 100 mM EtOH or 200 µM POA significantly decreased forskolin-stimulated CFTR Cl -currents.
In both cases, inhibition was voltage-independent and irreversible.
Intracellular ATP supplementation in human PDECs
Next we investigated the effect of ATP i supplementation on the inhibitory effect of 
Trypsin and PAR-2-AP inhibit CFTR
Exposure of PDECs to 10 µM trypsin did not affect the basal CFTR currents; however, administration of either 10 µM PAR-2-AP or 10 µM trypsin inhibited forskolin-stimulated CFTR currents by 51.7% ± 10.5% and 57.4% ± 4.0%,respectively. In both cases, the inhibition was voltage independent and irreversible. Pretreatment with either soybean trypsin inhibitor (SBTI; 10 µM) or PAR-2 antogonist (PAR-2-ANT; 10 µM) completely prevented the inhibitory effect of trypsin on the forskolin-stimulated CFTR currents. These results suggest that trypsin inhibits CFTR currents by activation of PAR-2. In the present study, we show that EtOH, its non-oxidative metabolite POAEE and the FA, POA strongly inhibit CFTR Cl -channel activity in guinea pig PDECs when measured using the whole cell configuration of the patch clamp technique. We demonstrated that 1 mM EtOH (blood alcohol level reached during moderate social drinking) had no effect on basal or forskolin-stimulated CFTR channel activity. However, at higher concentrations such as 10 or 100 mM (which is equivalent to a lethal blood alcohol level in humansEtOH increased the basal and decreased the forskolin-stimulated CFTR currents. The present observation that low concentrations of EtOH (1 mM) had no effect whereas high concentrations (10 and 100 mM)
DISCUSSION
inhibit secretagogue-stimulated CFTR activity is in agreement with previous observations that alcohol exerts dose-dependent effects on the pancreas. Using an equivalent concentration of mannitol, we show that the stimulatory effect of EtOH is likely to be due to an osmotic effect, whereas the inhibitory effect is independent of any the change in osmolarity. Several experimental studies have shown a key role of EtOH metabolites in the development of pancreatitis. Therefore, in this study we also investigated the effect of the oxidative and non-oxidative EtOH metabolites on the acitivity of CFTR. Previous studies have demonstrated that
Ac, an oxidative metabolite of EtOH, strongly inhibits NF-κB binding activityand cholecystokinin-induced secretionin isolated rat pancreatic acinar cells and, at higher concentrations, causes morphological alterations in the rat pancreas. In contrast, our study showed that Ac had no effect on CFTR activity or on ATP i ; furthermore, it did not cause any morphological changes in ductal cells even at high concentrations (5 mM), indicating that
PDECs are probably not involved in the toxic effect of Ac in the pancreas. On the contrary to oxidative metabolism, the pancreas has a very high capacity to metabolise EtOH through a non-oxidative pathway, and consequently the concentration of these metabolites is higher in the pancreas than in any other organ. Previous studies have shown that at relatively low concentrations FAEEs are able to induce pancreatic injury, whereas at higher concentrations they cause toxic calcium signalling in acinar cells and disrupt the mitochondrial oxidative chain, which leads to ATP i depletion and finally cell death. In addition, the pivotal role of FAEEs in the pathophysiology of alcoholic pancreatitis is also supposed by the fact that high concentrations of FAEEs have been detected in the pancreas at autopsy after acute alcohol intoxication and in chronic alcoholics. Our studies showed for the first time that the unsaturated FA, POA and its esterized form, POAEE reversibly and time-dependently inhibit CFTR activity in PDECs.
In the next step we wanted to identify the intracellular mechanism by which EtOH, this, inhibition of glycolytic and mitochondrial ATP production reduced CFTR currents to a similar degree to that caused by EtOH, POA and POAEE, which strongly suggests that depletion of ATP i is a key step in the inhibitory effect of these agents on CFTR. Based on these results, we tested whether administration of ATP i back to the cell via the patch pipette is able to prevent the inhibitory effect of EtOH, POA and POAA on CFTR. Addition of 5 mM intracellular ATP almost completely abolished the inhibitory effect of these agents on CFTR activity. Moreover similar results were found in Capan-1 cells, where supplementation of ATP i was also able to decrease the inhibitory effect of POA on CFTR.
In the second part of this thesis we investigated the effect of trypsin on CFTR activity.
It is generally believed that the earliest events inacutepancreatitisis the zymogen activation which is mediated by lysosomal hydrolases such as cathepsin B and produces active trypsin.
Active trypsin than activates other zymogens resulting in cell injury. Since acinar cells synthesize, store and secrete the inactive proforms of digestive enzymes and this cell type accounts for 80.3% of the total pancreas volume, most of the research on the effect of trypsin have been done on acinar cells. In contrast, much less studies have been done on ductal cells.
PAR-2 is a specific receptor of trypsin and it has been shown that activation of this receptor stimulates enzyme secretion from acinar cells. In the ductal cells, activation of PAR-2 is able to modulate the rate of HCO 3 -secretion. These studies mainly focused on the Cl -/HCO 3 -exchangers whereas no data is available regarding the effect of trypsin on the CFTR Cl -channel. Therefore, our next challenge was to identify whether trypsin can reduce ductal bicarbonate secretion via PAR-2 dependent inhibition of the CFTR Cl -channel in guinea pig
PDECs using the whole cell configuration of the patch clamp technique. We showed, that both trypsin and PAR-2-AP irreversibly decreased forskolin-stimulated CFTRcurrents in PDECs and this inhibitory effect could be completely prevented by SBTI or PAR-2-ANT.
Taken together we showed for the first time that high concentrations of EtOH, POAEE, POA and physiological concentration of trypsin and PAR-2-AP all strongly inhibit epithelial CFTR channel activity. Since the CFTR Cl -channel plays an essential role in ductal electrolyte and fluid secretion, we hypothesise that functional inhibition of this channel may be involved in the pathogenesis of AP. In addition, we found that the inhibitory effect of EtOH, POAEE and POA is mediated through the depletion of ATP i . Since the deleterious effects of EtOH and its metabolites could be prevented by maintaining cytosolic ATP levels we speculate that restoration of the intracellular energetic pool by ATP supplementation may represent a novel therapeutic target in the treatment of the disease.
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